» Articles » PMID: 39939502

Customizing Parkinson's Care: Sustaining Continuous Levodopa Therapy Post-gastrectomy

Overview
Journal Neurol Sci
Specialty Neurology
Date 2025 Feb 12
PMID 39939502
Authors
Affiliations
Soon will be listed here.
References
1.
Antonini A, Poewe W, Chaudhuri K, Jech R, Pickut B, Pirtosek Z . Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry. Parkinsonism Relat Disord. 2017; 45:13-20. DOI: 10.1016/j.parkreldis.2017.09.018. View

2.
Serva S, Bernstein J, Thompson J, Kern D, Ojemann S . An update on advanced therapies for Parkinson's disease: From gene therapy to neuromodulation. Front Surg. 2022; 9:863921. PMC: 9537763. DOI: 10.3389/fsurg.2022.863921. View

3.
Montgomery M, Miner N, Soileau M, McDonald D . Placement of the AbbVie PEG-J tube for the treatment of Parkinson's disease in the interventional radiology suite. Proc (Bayl Univ Med Cent). 2016; 29(4):420-422. PMC: 5023306. DOI: 10.1080/08998280.2016.11929495. View

4.
Thakkar S, Fung V, Merola A, Rollins M, Soileau M, Kovacs N . 24-Hour Levodopa-Carbidopa Intestinal Gel: Clinical Experience and Practical Recommendations. CNS Drugs. 2021; 35(2):137-149. PMC: 7907013. DOI: 10.1007/s40263-020-00782-w. View

5.
Olanow C, Kieburtz K, Odin P, Espay A, Standaert D, Fernandez H . Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study. Lancet Neurol. 2013; 13(2):141-9. PMC: 4643396. DOI: 10.1016/S1474-4422(13)70293-X. View